Clinical efficacy of transarterial chemoembolization combined with immunotherapy plustarget therapy for advanced unresectable intrahepatic cholangiocarcinoma[J]. Chinese Journal of Digestive Surgery, 2021, 20(102): 37-40. DOI: 10.3760/cma.j.cn115610-20211108-00551
Citation: Clinical efficacy of transarterial chemoembolization combined with immunotherapy plustarget therapy for advanced unresectable intrahepatic cholangiocarcinoma[J]. Chinese Journal of Digestive Surgery, 2021, 20(102): 37-40. DOI: 10.3760/cma.j.cn115610-20211108-00551

Clinical efficacy of transarterial chemoembolization combined with immunotherapy plus target therapy for advanced unresectable intrahepatic cholangiocarcinoma

  • Advanced intrahepatic cholangiocarcinoma(ICC) is one of the most common hepatic malignant tumors besides hepatocellular carcinoma, with occult onset, limited treatment and poor prognosis. Systemic treatment is a recommendable solution for advanced unresectable ICC. The authors reported the clinical experience of an ICC patient who underwent transarterial chemoembolization combined with immunotherapy plus target therapy
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return